Discrepancies between the outcome of animal and human studies on the mode of action of probucol
- 30 September 1986
- journal article
- editorial
- Published by Elsevier in Atherosclerosis
- Vol. 61 (3) , 249-251
- https://doi.org/10.1016/0021-9150(86)90146-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- The hypolipidemic action of probucolAtherosclerosis, 1985
- Sterol synthesis in vitro in freshly isolated blood mononuclear leukocytes from familial hypercholesterolemic patients treated with probucolBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- Effects of probucol on the in vivo plasma clearance of human low density lipoproteins in rabbits and on the expression of lipoprotein receptors in vitroAtherosclerosis, 1984
- Effect of probucol on the composition of lipoproteins and on VLDL apoprotein B turnoverAtherosclerosis, 1983
- The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemiaAtherosclerosis, 1982
- Metabolic studies with probucol in hypercholesterolaemiaAtherosclerosis, 1981
- Effect of probucol on cholesterol synthesis, plasma lipoproteins and the activities of lipoprotein and hepatic lipase in the ratAtherosclerosis, 1981
- Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesisAtherosclerosis, 1981
- Effect of probucol on cholesterol metabolism in the ratAtherosclerosis, 1980
- Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemiaAtherosclerosis, 1972